DUBLIN, March 4, 2020 / PRNewswire / – “Anesthetics Global Market Report 2020” has been added to ResearchAndMarkets.com’s offer.
The global anesthetic market was estimated to be around $ 9.32 billion in 2018 and is expected to decrease to $ 9.13 billion at a CAGR of -0.5% until 2022. The main market players are Baxter, Abbott Laboratories, AstraZeneca, Roche and B. Braun Melsungen.
North America was the largest anesthetic market region in 2017, followed by Europe. This region is expected to remain the largest over the next five years. The anesthetic market Asia Pacific is expected to record the highest CAGR over the 2018-2023 period.
The increase in the number of surgeries is one of the main drivers of the anesthetic market due to the applications of anesthetic drugs during surgical procedures. This increase is mainly due to the increase in incidents of injuries and accidents requiring surgical interventions. For example, according to the 2018 WHO Global Road Safety Situation Report, the number of road accidents reached 1.35 million in 2016, with around 64 deaths per 100,000 vehicles.
Strict guidelines and regulations imposed by regulatory bodies are one of the important constraints for the anesthetic market. These guidelines include the conduct of clinical trials of newly developed drugs, standards for patient safety and monitoring of patients under anesthesia. Compliance with these guidelines and obtaining regulatory approvals are time consuming and have a negative impact on the growth of the anesthetic market. For example, the American Society of Anesthesiologists imposes various standards that apply to anesthesia care and patient supervision, including standards of pre-, basic, and post-anesthesia care and supervision.
Growing consolidation in the form of acquisitions is an emerging trend in the anesthetic market. This is mainly due to the high level of investment in R&D and intellectual property (IP) necessary to create companies that manufacture anesthetic drugs. In this regard, mergers and acquisitions are seen as cost-effective and rapid methods. Some of the notable acquisitions in recent years include the acquisition of MyoScience by Pacira for $ 220 million in 2019, acquisition of Claris Injectables by Baxter for $ 625 million in 2017, acquisition of the GSK anesthetics portfolio by Aspen for $ 238.7 million in 2017, and acquisition of Hospira by Pfizer for $ 17 billion in 2015.
In 1977, the U.S. Food and Drug Administration released a document outlining the guidelines for clinical trials of general anesthetics. This document provides educational information on how to select clinical subjects, appropriate drug administration procedures, and important parameters to note. Examples of important parameters include signs of relaxation, salivation and feelings of irritation after administration of the anesthetic. This document was revised in 1982 and is still used today. Such regulations should control the general market for anesthetics.
Key topics covered
1. Summary
2. Characteristics of the anesthetic market
3. Size and growth of the anesthetic market
3.1. World historical anesthetic market, 2015-2019, billions of dollars
3.1.1. Market drivers
3.1.2. Market restrictions
3.2. Global anesthesia forecast market, 2019 – 2022F, 2025F, 2030F, billions of $
3.2.1. Market drivers
3.2.2. Market restrictions
4. Segmentation of the anesthetic market
4.1. World anesthetic market, segmentation by type, historical and forecast, 2015-2019, 2022F, 2025F, 2030F, in billions of dollars
- General anaesthesia
- Local anesthetics
4.2. World anesthetics market, segmentation by application, history and forecast, 2015-2019, 2022F, 2025F, 2030F, in billions of dollars
- General surgeries
- Plastic surgery
- Cosmetic surgeries
- Dental surgeries
- Other applications
4.3. Global anesthetic market, segmentation by route, historical and forecast, 2015-2019, 2022F, 2025F, 2030F, in billions of dollars
- Inhalation anesthesia drugs
- Intravenous anesthesia drugs
- Topical anesthesia medications
4.4. World anesthetics market, segmentation by local anesthetics, historical and forecast, 2015-2019, 2022F, 2025F, 2030F, in billions of dollars
- Bupivacaine
- Ropivacaine
- Lidocaine
- Chloroprocaine
- Artican
- Benzocaine
- Other local anesthesia drugs
4.5. World anesthetic market, segmentation by general anesthesia, historical and forecast, 2015-2019, 2022F, 2025F, 2030F, in billions of dollars
- Propofol
- Sevoflurane
- Desflurane
- Dexmedetomidine
- Remifentanil
- Midazolam
- Other general anesthesia medications
5. Regional and national analysis of the anesthetic market
5.1. World anesthetic market, divided by region, historical and forecast, 2015-2019, 2022F, 2025F, 2030F, in billions of dollars
5.2. World anesthetic market, divided by country, historical and forecast, 2015-2019, 2022F, 2025F, 2030F, in billions of dollars
Companies mentioned
- Abbott Laboratories
- AbbVie Inc.
- Aspen
- AstraZeneca
- B. Braun Melsungen AG
- Baxter
- Boehringer Ingelheim International GmbH
- Eisai Co. Ltd.
- F. Hoffmann-La Roche AG
- Fresenius SE & Co. KGaA
- Hameln Pharmaceuticals
- Hikma Pharmaceuticals PLC
- Hospira
- Maruishi Pharmaceuticals
- MYLAN N.V.
- Novartis International AG
- Pacira Pharmaceuticals Inc.
- PAION AG
- Pfizer
- Piramal Group
For more information on this report, visit https://www.researchandmarkets.com/r/cpz86i
Research and markets also offer personalized research services offering targeted, comprehensive and personalized research.
Media contact:
Research and markets
Laura Wood, Senior Manager
[email protected]
For E.S.T opening hours, call + 1-917-300-0470
For toll-free calls to the United States / CAN + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900
American fax: 646-607-1907
Fax (outside the United States): + 353-1-481-1716
SOURCE Research and markets
Related links
http://www.researchandmarkets.com
